Orange Book product · Generic (ANDA)
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Generic (ANDA)ANDA 214053DISCN APOTEX
At a glance
May 17, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 17, 2024
2 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Strength
120MG;EQ 15MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 214053
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
